Related Experiment Video
Updated: Jan 11, 2026
Vascular Occlusion Training for Inclusion Body Myositis: A Novel Therapeutic Approach
Published on: June 5, 2010
WHERE ARE THE ORTHOPEDIC ONCOLOGY CENTERS IN THE BRAZILIAN UNIFIED HEALTH SYSTEM (SUS)?
Geraldo Mota Gonçalves1, Danilo Arruda de Souza1, Edgard Eduard Engel1
1Universidade de Sao Paulo (USP), Faculdade de Medicina de Ribeirao Preto, Ribeirao Preto, Sao Paulo, SP, Brazil.
Objective:
To identify and analyze the geographical distribution, surgical volume, and population adequacy of Orthopedic Oncology Centers (OOCs) within the Brazilian Unified Health System (SUS).
Methods:
We evaluated 11,139 procedures recorded in Hospitalization Authorizations (AIHs) between 2008 and 2019, including "hemipelvectomy in oncology" and "resection of bone tumors with replacement or reconstruction." Hospitals performing both procedures and at least three hemipelvectomies during this period were classified as OOCs.
Results:
A total of 58 OOCs were identified in 18 states, accounting for 79.5% of all procedures. Most patients (93.7%) were treated in their home state. High-Volume Centers (HVCs) performed 95% of the surgeries, while Low-Volume Centers (LVCs) were responsible for only 5%. The Northeast region concentrated 39.1% of procedures, while the South had the highest number of OOCs per population.
Conclusion:
The geographical distribution of OOCs in Brazil is relatively adequate; however, procedures are highly concentrated in a few high-volume centers. This centralization may be associated with better clinical outcomes, reinforcing the need for policies that encourage specialized treatment in reference units. Level of Evidence III; Cross-Sectional Observational Study .
Related Concept Videos
02:56Treatment Resistant Cancers
01:29Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
01:11Secondary Healthcare System
01:21Tertiary Healthcare System
01:20Integrated Healthcare System
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...